<Record>
<Term>Doxaminol</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Beta-Adrenergic Agonist</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Adjuvant/Adrenergic Agent/Beta-Adrenergic Agonist/Doxaminol</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Doxaminol</BroaderTerm>
<BroaderTerm>Beta-Adrenergic Agonist</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Adjuvant</BroaderTerm>
<BroaderTerm>Adrenergic Agent</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>BM 10 188</Synonym>
<Synonym>DOXAMINOL</Synonym>
<Synonym>Doxaminol</Synonym>
<Description>A synthetic partial beta-adrenergic agonist with sympathomimetic activity. Doxaminol may bind to and stimulate beta-1-adrenergic receptors located in the myocardium. As a result, it leads to a positive inotropic effect and increases in cardiac output.</Description>
<Source>NCI Thesaurus</Source>
</Record>
